title: Composite lymphoma after chemotherapy with regressed diffuse large B-cell lymphoma and transformed cytotoxic T-cell lymphoma.
authors.forename: Janelyn A L
authors.initials: JA
authors.lastname: Dy
authors.forename: Shang-Wen
authors.initials: SW
authors.lastname: Chen
authors.forename: Chia-Hao
authors.initials: CH
authors.lastname: Chang
authors.forename: Sheng-Tsung
authors.initials: ST
authors.lastname: Chang
authors.forename: Szu-Yin
authors.initials: SY
authors.lastname: Kuo
authors.forename: Hongtao
authors.initials: H
authors.lastname: Ye
authors.forename: Fatheha
authors.initials: F
authors.lastname: Khanom
authors.forename: Betty Nuako
authors.initials: BN
authors.lastname: Bandoh
authors.forename: Hongxiang
authors.initials: H
authors.lastname: Liu
authors.forename: Shih-Sung
authors.initials: SS
authors.lastname: Chuang
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D058617:Composite Lymphoma / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology*; D018450:Disease Progression; D017809:Fatal Outcome; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000175:diagnosis / Q000473:pathology*; D016399:Lymphoma, T-Cell / Q000175:diagnosis / Q000473:pathology*; D008297:Male; D013602:T-Lymphocytes, Cytotoxic / Q000473:pathology*